Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Latest, FY2025
-25,107
Period ended Dec 31, 2025
Change on a year earlier
-9.0%
-27,590 in FY2024
History
18 years
Since FY2008
Sources
18
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Retained earnings (accumulated deficit) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -25,107 | -9.0% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | -27,590 | +3.9% | Form 10-K (filed 2025-02-14) ↗ |
| FY2023 | Dec 31, 2023 | -26,549 | -7.2% | Form 10-K (filed 2024-02-14) ↗ |
| FY2022 | Dec 31, 2022 | -28,622 | +16.3% | Form 10-K (filed 2023-02-09) ↗ |
| FY2021 | Dec 31, 2021 | -24,600 | +14.9% | Form 10-K (filed 2022-02-16) ↗ |
| FY2020 | Dec 31, 2020 | -21,408 | +0.4% | Form 10-K (filed 2021-02-09) ↗ |
| FY2019 | Dec 31, 2019 | -21,330 | +18.7% | Form 10-K (filed 2020-02-12) ↗ |
| FY2018 | Dec 31, 2018 | -17,977 | +254.4% | Form 10-K (filed 2019-02-13) ↗ |
| FY2017 | Dec 31, 2017 | -5,072 | +1,058.0% | Form 10-K (filed 2018-02-13) ↗ |
| FY2016 | Dec 31, 2016 | -438 | -79.0% | Form 10-K (filed 2017-02-14) ↗ |
| FY2015 | Dec 31, 2015 | -2,086 | -54.9% | Form 10-K (filed 2016-02-16) ↗ |
| FY2014 | Dec 31, 2014 | -4,624 | -39.4% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | -7,634 | -26.8% | Form 10-K (filed 2014-02-24) ↗ |
| FY2012 | Dec 31, 2012 | -10,423 | +16.9% | Form 10-K (filed 2013-02-27) ↗ |
| FY2011 | Dec 31, 2011 | -8,919 | +154.2% | Form 10-K (filed 2012-02-29) ↗ |
| FY2010 | Dec 31, 2010 | -3,508 | -18.8% | Form 10-K (filed 2011-02-25) ↗ |
| FY2009 | Dec 31, 2009 | -4,322 | -23.8% | Form 10-K (filed 2010-03-01) ↗ |
| FY2008 | Dec 31, 2008 | -5,673 | – | Form 10-Q (filed 2009-08-10) ↗ |
Cite this data
StockData. (2026). Amgen Retained earnings (accumulated deficit) ($M) ($M), annual FY2008–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_re
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.